These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17482461)

  • 1. Highly potent growth hormone secretagogues.
    Lu Z; Tata JR; Cheng K; Wei L; Chan WW; Butler B; Schleim KD; Jacks TM; Hickey G; Patchett AA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3657-9. PubMed ID: 17482461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.
    Li J; Chen SY; Murphy BJ; Flynn N; Seethala R; Slusarchyk D; Yan M; Sleph P; Zhang H; Humphreys WG; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4072-4. PubMed ID: 18554903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor.
    Witherington J; Abberley L; Bellenie BR; Boatman R; Collis K; Dean DK; Gaiba A; King NP; Shuker N; Steadman JG; Takle AK; Sanger G; Butler S; McKay F; Muir A; Winborn K; Ward RW; Heightman TD
    Bioorg Med Chem Lett; 2009 Feb; 19(3):684-7. PubMed ID: 19128969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
    Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues.
    Chen MH; Pollard PP; Patchett AA; Cheng K; Wei L; Chan WW; Butler B; Jacks TM; Smith RG
    Bioorg Med Chem Lett; 1999 May; 9(9):1261-6. PubMed ID: 10340611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues.
    Barakat KJ; Cheng K; Chan WW; Butler BS; Jacks TM; Schleim KD; Hora DF; Hickey GJ; Smith RG; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1431-6. PubMed ID: 9871779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spiro-piperidine azetidinones as potent TRPV1 antagonists.
    Xiao D; Palani A; Aslanian R; McKittrick BA; McPhail AT; Correll CC; Phelps PT; Anthes JC; Rindgen D
    Bioorg Med Chem Lett; 2009 Feb; 19(3):783-7. PubMed ID: 19114307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of orally active inhibitors of plasminogen activator inhibitor-1 (PAI-1) production.
    Miyazaki H; Ogiku T; Sai H; Ohmizu H; Murakami J; Ohtani A
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6419-22. PubMed ID: 18993062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent 3-spiropiperidine growth hormone secretagogues.
    Yang L; Morriello G; Prendergast K; Cheng K; Jacks T; Chan WW; Schleim KD; Smith RG; Patchett AA
    Bioorg Med Chem Lett; 1998 Jan; 8(1):107-12. PubMed ID: 9925440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
    Patchett AA; Nargund RP; Tata JR; Chen MH; Barakat KJ; Johnston DB; Cheng K; Chan WW; Butler B; Hickey G
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7001-5. PubMed ID: 7624358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between two classes of selective EP(3) antagonists and their biological activities.
    Belley M; Chan CC; Gareau Y; Gallant M; Juteau H; Houde K; Lachance N; Labelle M; Sawyer N; Tremblay N; Lamontagne S; Carrière MC; Denis D; Greig GM; Slipetz D; Gordon R; Chauret N; Li C; Zamboni RJ; Metters KM
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5639-42. PubMed ID: 16931013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.
    Hansen TK; Ankersen M; Raun K; Hansen BS
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1915-8. PubMed ID: 11459660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of tricyclic heterocycle-tetraamine conjugates as potent NMDA channel blockers.
    Takayama H; Yaegashi Y; Kitajima M; Han X; Nishimura K; Okuyama S; Igarashi K
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4729-32. PubMed ID: 17624774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of the oxindole growth hormone secretagogues.
    Tokunaga T; Hume WE; Nagamine J; Kawamura T; Taiji M; Nagata R
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1789-92. PubMed ID: 15780607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted bridged phenyl piperidines: orally active growth hormone secretagogues.
    Lu Z; Tata JR; Cheng K; Wei L; Chan WW; Butler B; Schleim KD; Jacks TM; Hickey G; Patchett AA
    Bioorg Med Chem Lett; 2003 May; 13(10):1817-20. PubMed ID: 12729672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorinated 9H-xanthene-9-carboxylic acid oxazol-2-yl-amides as potent, orally available mGlu1 receptor enhancers.
    Vieira E; Huwyler J; Jolidon S; Knoflach F; Mutel V; Wichmann J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1666-9. PubMed ID: 19233648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel orally active growth hormone secretagogues.
    Hansen TK; Ankersen M; Hansen BS; Raun K; Nielsen KK; Lau J; Peschke B; Lundt BF; Thøgersen H; Johansen NL; Madsen K; Andersen PH
    J Med Chem; 1998 Sep; 41(19):3705-14. PubMed ID: 9733496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists.
    Shen DM; Zhang F; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Dragovic J; Feeney WP; Jiang G; McCann PE; Mock S; Qureshi SA; Saperstein R; Shen X; Tamvakopoulos C; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4564-9. PubMed ID: 16102966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.
    Hernández AS; Swartz SG; Slusarchyk D; Yan M; Seethala RK; Sleph P; Grover G; Dickinson K; Giupponi L; Harper TW; Humphreys WG; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2067-72. PubMed ID: 18282707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonists.
    Dyck B; Zhao L; Tamiya J; Pontillo J; Hudson S; Ching B; Heise CE; Wen J; Norton C; Madan A; Schwarz D; Wade W; Goodfellow VS
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4237-42. PubMed ID: 16762549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.